Aims & Scope – Current Rheumatology Reviews

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Latest Issue: Volume 18 , Issue 3 , 2022

Aims & Scope

Current Rheumatology Reviews publishes frontier reviews/mini-reviews, original research articles, drug clinical trial studies and guest-edited thematic issues on all the latest advances in rheumatology and its related areas, e.g. pharmacology, pathogenesis, epidemiology, clinical care and therapy. The journal’s aim is to publish the highest quality review articles dedicated to clinical, therapeutic, and laboratory research about diseases that affect joints and soft and connective tissues such as arthritis, rheumatism and other chronic degenerative autoimmune inflammatory diseases. Read now:

Drug therapy for SARS-CoV-2 and Seizures based on Mechanistic Targets

Divya Goel, Ankit Srivastava, Ángel Aledo-Serrano, Anuja Krishnan, Divya Vohora

DOI: 10.2174/1874467214666211013122528

What is it about?

As a result of the SARS-CoV-2 coronavirus disease (COVID-19), the entire world was come to a halt. This illness has been linked to neurological symptoms such as headache, dizziness, stroke, or seizures, in addition to atypical pneumonia and lung disease symptoms. It is still unclear whether SARS-CoV-2 has a direct or indirect link to seizures. In this study, we identified the most likely drug candidate for COVID-19 in people with epilepsy or COVID-19 patients experiencing seizures using a literature search and the Comparative Toxicogenomics Database. After searching for common molecular targets affecting SARS-CoV-2 and seizures, we discovered ivermectin, dexamethasone, anakinra, and tocilizumab for protection against both COVID-19 and seizures. Additionally, we identified valproic acid as the most likely pharmacotherapy for COVID-19 individuals who were suffering seizures among the antiseizure drugs.

Why is it important?

The findings will serve as the starting point for more research on the aetiology and therapeutic targeting techniques for this newly discovered infection that causes seizures or in individuals with epilepsy. Read now:

Kudos Article – Discovery of natural anti-cancerous therapeutic molecules that target topoisomerases

Swati Singh, Veda P. Pandey, Kusum Yadav, Anurag Yadav, U. N. Dwivedi

DOI: 10.2174/1389203721666200918152511

What is it about?

Thus, the present review describes the anticancer potential of plant-derived secondary metabolites belonging to alkaloids, flavonoids and terpenoids directed against topoisomerases. Furthermore, in view of the recent advances made in the field of computer-aided drug design, the present review also discusses the use of computational approaches such as ADMET, molecular docking, molecular dynamics simulation and QSAR to assess and predict the safety, efficacy, potency and identification of these potent anti-cancerous therapeutic molecules.

Why is it important?

Cancer is the second leading cause of global deaths of millions of people. Some of the bottlenecks in the successful development of anticancer drugs include the absence of cancer specificity, toxicity and the development of multi-drug resistance among cancerous cells. Since ancient times, plant-derived products are being used as therapeutic agents against several diseases. The development of cancer prevention and healthcare products from natural products has a broader prospect, greater economic and social benefits compared with prevalent synthetic anticancerous drugs. Read now:

Aims & Scope – Current Women`s Health Reviews

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Latest Issue: Volume 19 , Issue 1 , 2023

Aims & Scope

Current Women’s Health Reviews publishes original research papers, frontier reviews/mini-reviews, drug clinical trial studies and guest-edited thematic issues written by leaders working in the field of obstetrics and gynecology. This journal covers articles based on pregnancy, fetal health, labor, puerperium, gynecologic oncology, urogynecology, fertility, infertility and contraception. It includes submissions related to the health and diseases of female genital organs and their effect on women’s overall health, and publishes topics related to women’s office practices and their effect on women’s mental health. The journal is essential reading for all clinicians and researchers in the fields of obstetrics and gynecology. Read now:

Aims & Scope – Drug Delivery Letters

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Latest Issue: Volume 12 , Issue 2 , 2022

Aims & Scope

Drug Delivery Letters publishes short papers and mini-reviews in all important aspects of drug delivery, gene delivery, and drug targeting. Short papers report seminal results and research approaching conclusion of importance in the field.

The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The manuscript submission process is fully electronic to ensure rapid publication of research results. Read now:

Highlighted Article Flyer for the journal “Current Medicinal Chemistry”


Upcoming Thematic Issue – Obstetrics and Anaesthesia, the Link Explored


New Issue ::: Current Genomics 17, Issue 4

Current Genomics is a peer-reviewed journal that provides essential reading for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in genome science and systems modeling.

Current Genomics publishes three types of peer-reviewed articles including:

  1. i) High-quality research papersreporting on new and original data generated at the genome scale level, including meta-analysis studies. Systems biology, molecular systems modeling, molecular evolution, developmental biology, aging research and human disease research are topics of particular interest. Position papers dealing with new or complex methodological approaches whether experimental or mathematical are greatly welcome in this section.
  2. ii) Authoritative and comprehensive reviewsfrom widely-recognized experts, covering all the latest and outstanding developments in genome science and computational/systems biology. Proposals for mini-hot topics (2-3 review papers) and full hot topics (6-8 review papers) are welcome in this section and they should not contain original data. Guest edited issues provide expert views on specific questions giving an extensive and comprehensive analysis of a specific field of activities in genomics. All aspects of genetic analysis and gene function will be covered, particularly in the growing areas of human genomics, functional genomics and next generation sequencing, molecular evolution, developmental biology, aging research and systems/statistical modeling.

iii) Opinion papers from internationally and widely recognized experts addressing contemporary questions and issues in the field of genome science and systems biology and basic and clinical research practices.


Articles from the journal Current Genomics, Volume 17, Issue 4:



For details on the articles, please visit this link ::


New Issues of various Bentham Science Journals

Mini-Reviews in Organic Chemistry , 13 Issue 3

Current HIV Research, 14 Issue 4

Combinatorial Chemistry & High Throughput Screening, 19 Issue 6

Infectious Disorders – Drug Targets, 16 Issue 2

Pharmaceutical Nanotechnology, 4 Issue 2

Drug Metabolism Letters, 10 Issue 2

Cardiovascular & Hematological Agents in Medicinal Chemistry, 14 Issue 1

Current Pharmaceutical Design, 22 Issue 23

Current Pharmaceutical Design, 22 Issue 24

Current Bioinformatics, 11 Issue 3

Recently published 2

A very Happy Birthday to Dr. Arduino A. Mangoni!

31 jul

Editor-in-Chief: Current Clinical Pharmacology

Dr. Arduino A. Mangoni
Department of Clinical Pharmacology,
Clinical Pharmacologist and General Physician,
Flinders University and Flinders Medical Centre,
Bedford Park, SA 5042,

%d bloggers like this: